Did You Know?
Participating in an OHC clinical trial should be one of your first steps in cancer care, not the last.
Clinical trials allow you to take part in the advancement of science and medical care for yourself and others. You may be able to take part in research studies that include investigational drugs, diagnostic tests, or preventative measures. This helps in the development of new medicines and treatments that may offer better care for life-threatening and chronic diseases. Whatever your reason for participating, you will continue to receive quality cancer care from OHC.
Before you enroll in a study, talk to your physician or nurse navigator. They can tell you about studies that match your situation, as well as any risks and benefits. You should also receive information about any financial obligations. All of this information will be provided in writing — in what’s called an “Informed Consent Form.”
What to Expect
You may receive a physical exam and your medical history will be reviewed. Once you’re enrolled in the study, feel free to discuss your medical care with your physician or research staff.
It’s important that you take all your medication as prescribed and keep all scheduled visits. It’s also important for you to answer questions honestly about how you feel or whether you’ve been taking your medication as scheduled. OHC study physicians need to record any symptoms, no matter how minor they may seem. If you miss a dose or do not take it on schedule, you should tell your physician or research staff.
Your Informed Consent Form will list the side effects of the medication used in your study. Because some medications are new, some side effects may still be unknown and could have serious side effects.
After the Study
After the study is complete, your care may be followed every few months for many years to see how you’re doing. If you change to another health care provider, our research staff may contact you by phone.
Collected information is analyzed to help determine drug safety, effectiveness, and side effects. FDA medical advisers and specialists closely review this data before considering any new drug for approval. After a drug has been approved by the FDA, studies continue to compare the new drug with other drugs already on the market. Other studies may research whether it can be safely administered to children or special populations, as well as its long-term effectiveness and impact on quality of life.